Evosep
Bioscience company working on the standardization of proteomics for clinical use
Evosep has raised €37M across 1 funding round from 1 investor, most recently a round in Jan 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkwww.evosep.com ↗
Total raised
€37M
€37,397,158
Funding rounds
1
Investors
1
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearEvosep — funding by year — interactive chart.
Data table
| Evosep — funding by year | |
|---|---|
| 2023 | €37M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-09 | Other | €37M | Novo Holdings | View deal → |
Investors
1Related news
- Evosep Receives $40M Investment From Novo Holdingsfinsmes.com · 2023-01
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData